Academy of Clinical Thyroidologists
| Industry | Clinical Medicine |
|---|---|
| Headquarters | Washington,D.C USA |
Key people |
John Woody Sistrunk, M.D. President Mark A. Lupo, M.D., F.A.C.E., E.C.N.U. Secretary |
| Website | http://www.thyroidologists.org/ |
The Academy of Clinical Thyroidologists (ACT) was founded in May 2005 at the annual meeting of the Association of Clinical Endocrinologists (AACE) in Washington DC. The Academy is a professional society consisting of 32 members from the U.S. and Italy who specialize in clinical thyroidology. ACT enourages skill development in diagnostic and interventional ultrasound, nuclear thyroidology, and cytopathology to promote excellence in clinical practice and optimal outcomes for patients.[1]
Charter
The academy meets twice a year, and accepts board-certified new members who pledge to provide patients with state-of-the-art thyroid treatment; for example ultrasound, ultrasound guided biopsy, Interventional thyroid ultrasound to treat thyroid cysts, and cancer lymph nodes with ethanol, percutaneous ethanol injections (PEI), nuclear thyroid studies, such as I/123,131 uptakes, scans, and therapy doses of I/131 for Thyroid Cancer, Graves' disease, Toxic Nodular Goiter, and large obstructive Nontoxic Nodular Goiters.
Goals
Academy of Clinical Thyroidologists corroborates research and development in the field of endocrinology. The goals include:[2]
- To certify endocrinologists in diagnostics (Ultrasound, Nuclear thyroidology and cytopathology).
- To encourage and guide endocrinologists in honing their skills.
- To conduct annual meetings to meet, share and discuss new ideas.
- To collaborate and foster with National & International organizations.
- To design new programs to train professionals in standard procedures.
References
- ↑ "Goals and mission statement". Academy of Clinical Thyroidologists (ACT). Archived from the original on 27 June 2007. Retrieved 2007-07-04.
- ↑ "About us". ACT website. Retrieved 7 February 2014.